Ustekinumab Dose Escalation Is Effective in Treatment of Crohn's Disease

被引:4
|
作者
Cohen, Erica [1 ]
Ha, Christina [1 ]
Syal, Gaurav [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源
关键词
D O I
10.14309/01.ajg.0000592160.21664.18
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
656
引用
收藏
页码:S384 / S385
页数:2
相关论文
共 50 条
  • [1] EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN CROHN'S DISEASE
    Ollech, Jacob
    Normatov, Inessa
    Peleg, Noam
    Patel, Shivani
    Rai, Victoria
    Wang, Jingzhou D.
    Yi, Yangtian
    Singer, Jorie
    Dalal, Sushila
    Sakuraba, Atsushi
    Cohen, Russell D.
    Rubin, David T.
    Pekow, Joel R.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S961 - S961
  • [2] Ustekinumab use in Crohn's disease: effectiveness of dose escalation
    Greenup, A.
    Rosenfeld, G.
    Bressler, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S400 - S400
  • [3] Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease
    Ollech, Jacob E.
    Normatov, Inessa
    Peleg, Noam
    Wang, Jingzhou
    Patel, Shivani A.
    Rai, Victoria
    Yi, Yangtian
    Singer, Jorie
    Dalal, Sushila R.
    Sakuraba, Atsushi
    Cohen, Russell D.
    Rubin, David T.
    Pekow, Joel
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (01) : 104 - 110
  • [4] Factors Associated With Ustekinumab Dose Escalation in Patients With Crohn's Disease
    Njie, Cheikh
    Dalal, Rahul S.
    Allegretti, Jessica R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S368 - S368
  • [5] USTEKINUMAB DOSE ESCALATION EFFECTIVE IN REAL-WORLD USE FOR LUMINAL AND PERIANAL CROHN'S DISEASE
    Glass, Jason
    Alsamman, Yasser
    Chittajallu, Punya
    Ahmed, Tasneem
    Fudman, David
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S123 - S124
  • [6] USTEKINUMAB DOSE ESCALATION EFFECTIVE IN REAL-WORLD USE FOR LUMINAL AND PERIANAL CROHN'S DISEASE
    Glass, Jason
    Alsamman, Yasser
    Petrasek, Jan
    Chittajallu, Punya
    Ahmed, Tasneem
    Fudman, David
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S960 - S961
  • [7] USTEKINUMAB DOSE ESCALATION EFFECTIVE IN REAL-WORLD USE FOR LUMINAL AND PERIANAL CROHN'S DISEASE
    Glass, Jason
    Alsamman, Yasser
    Chittajallu, Punya
    Ahmed, Tasneem
    Fudman, David
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S76 - S76
  • [8] Ustekinumab dose escalation improves clinical responses in refractory Crohn's disease
    Haider, Syedreza A.
    Yadav, Abhijeet
    Perry, Courtney
    Su, Leon
    Akanbi, Olalekan
    Kudaravalli, Praneeth
    Tripathi, Nishant
    Hashim, Mahmoud A.
    Abdelsalam, Mohammed
    Hussein, Mohamed
    Elkheshen, Ahmed
    Patel, Vihang
    Ali, Saad Emhmed
    Lamb, Latoya
    Ingram, Karen
    Mayne, Casie
    Stuffelbeam, Amy B.
    Flomenhoft, Deborah
    Stromberg, Arnold
    Barrett, Terrence A.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [9] Effectiveness and safety of ustekinumab dose escalation in Crohn's disease: a multicenter observational study
    Olmedo-Martin, Raul
    Vazquez-Moron, Juan Maria
    Martin-Rodriguez, Maria del Mar
    Lazaro-Saez, Marta
    Hernandez-Martinez, Alvaro
    Arguelles-Arias, Federico
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (12) : 686 - 692
  • [10] Effect of Ustekinumab Dose Escalation on Recapturing Clinical Response in Patients With Crohn's Disease
    Bundschuh, Mark
    McDonough, Gregory
    Kumar, Priyanka
    Kozuch, Patricia
    Shivashankar, Raina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S452 - S452